Page 423 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 21 Mast Cell Tumors 401

158. Frimberger AE, Moore AS, LaRue SM, et al.: Radiotherapy of 180. Jaffe MH, Hosgood G, Kerwin SC, et al.: Deionised water as an
incompletely resected, moderately differentiated mast cell tumors adjunct to surgery for the treatment of canine cutaneous mast cell
in the dog: 37 cases (1989-1993), J Am Anim Hosp Assoc 33:320– tumours, J Small Anim Pract 41:7–11, 2000.
VetBooks.ir 159. Poirier VJ, Adams WM, Forrest LJ, et al.: Radiation therapy for 181. Brocks BA, Neyens IJ, Teske E, et al.: Hypotonic water as adjuvant ther-
324, 1997.
apy for incompletely resected canine mast cell tumors: a randomized,
incompletely excised grade II canine mast cell tumors, J Am Anim
double-blind, placebo-controlled study, Vet Surg 37:472–478, 2008.
Hosp Assoc 42:430–434, 2006. 182. Asboe-Hanson G: The mast cell: cortisone action on connective
160. Hosoya K, Kisseberth WC, Alvarez FJ, et al.: Adjuvant CCNU tissue, Proc Soc Exp Biol Med 80:677–679, 1952.
(lomustine) and prednisone chemotherapy for dogs with incom- 183. Bloom F: Effect of cortisone on mast cell tumors (mastocytoma) of
pletely excised grade 2 mast cell tumors, J Am Anim Hosp Assoc the dog, Proc Soc Exp Biol Med 80:651–654, 1952.
45:14–18, 2009. 184. Brodey RS, McGrath JT, Martin JE: Preliminary observations on
161. Davies DR, Wyatt KM, Jardine JE, et al.: Vinblastine and prednis- the use of cortisone in canine mast cell sarcoma, J Am Vet Med Assoc
olone as adjunctive therapy for canine cutaneous mast cell tumors, 123:391–393, 1953.
J Am Anim Hosp Assoc 40:124–130, 2004. 185. Stanclift RM, Gilson SD: Evaluation of neoadjuvant prednisone
162. Vincenti S, Findji F: Influence of treatment on the outcome of dogs administration and surgical excision in treatment of cutaneous
with incompletely excised grade-2 mast cell tumors, Schweiz Arch mast cell tumors in dogs, J Am Vet Med Assoc 232:53–62, 2008.
Tierheilkd 159:171–177, 2017. 186. McCaw DL, Miller MA, Ogilvie GK, et al.: Response of canine
163. Hahn KA, King GK, Carreras JK: Efficacy of radiation therapy for mast cell tumors to treatment with oral prednisone, J Vet Intern
incompletely resected grade-III mast cell tumors in dogs: 31 cases Med 8:406–408, 1994.
(1987-1998), J Am Vet Med Assoc 224:79–82, 2004. 187. Takahashi T, Kadosawa T, Nagase M, et al.: Inhibitory effects of
164. Kry KL, Boston SE: Additional local therapy with primary re-excision glucocorticoids on proliferation of canine mast cell tumor, J Vet
or radiation therapy improves survival and local control after incom- Med Sci 59:995–1001, 1997.
plete or close surgical excision of mast cell tumors in dogs, Vet Surg 188. Dobson J, Cohen S, Gould S: Treatment of canine mast cell
43:182–189, 2014. tumours with prednisolone and radiotherapy, Vet Comp Oncol
165. Misdorp W: Incomplete surgery, local immunostimulation, and 2:132–141, 2004.
recurrence of some tumour types in dogs and cats, Vet Q 9:279– 189. Matsuda A, Tanaka A, Amagai Y, et al.: Glucocorticoid sensitivity
286, 1987. depends on expression levels of glucocorticoid receptors in canine neo-
166. Lagoretta RA, Denman DL, Kelley MC, et al.: Use of hyperthermia plastic mast cells, Vet Immunol Immunopathol 144:321–328, 2011.
and radiotherapy in treatment of a large mast cell sarcoma in a dog, 190. McCaw DL, Miller MA, Bergman PJ, et al.: Vincristine therapy for
J Am Vet Med Assoc 193:1545–1548, 1988. mast cell tumors in dogs, J Vet Intern Med 11:375–378, 1997.
167. Northrup NC, Roberts RE, Harrell TW, et al.: Iridium-192 inter- 191. Rassnick KM, Moore AS, Williams LE, et al.: Treatment of canine
stitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors with CCNU (lomustine), J Vet Intern Med
mast cell tumors, J Am Anim Hosp Assoc 40:309–315, 2004. 13:601–605, 1999.
168. Frimberger AE, Moore AS, Cincotta L, et al.: Photodynamic ther- 192. Rassnick KM, Al-Sarraf R, Bailey DB, et al.: Phase II open-label
apy of naturally occurring tumors in animals using a novel benzo- study of single-agent hydroxyurea for treatment of mast cell
phenothiazine photosensitizer, Clin Cancer Res 4:2207–2218, 1998. tumours in dogs, Vet Comp Oncol 8:103–111, 2010.
169. Tanabe S, Yamaguchi M, Iijima M, et al.: Fluorescence detection 193. Cooper M, Tsai X, Bennett P: Combination CCNU and vinblas-
of a new photosensitizer, PAD-S31, in tumour tissues and its use tine chemotherapy for canine mast cell tumours: 57 cases, Vet
as a photodynamic treatment for skin tumours in dogs and a cat: a Comp Oncol 7:196–206, 2009.
preliminary report, Vet J 167:286–293, 2004. 194. Grant IA, Rodriguez CO, Kent MS, et al.: A phase II clinical trial
170. Rogers KS: Common questions about diagnosing and treating of vinorelbine in dogs with cutaneous mast cell tumors, J Vet Intern
canine mast cell tumors, Vet Med 88:246–250, 1993. Med 22:388–393, 2008.
171. Case A, Burgess K: Safety and efficacy of intralesional triamcino- 195. Taylor F, Gear R, Hoather T, et al.: Chlorambucil and predniso-
lone administration for treatment of mast cell tumors in dogs: 23 lone chemotherapy for dogs with inoperable mast cell tumours: 21
cases (2005-2011), J Am Vet Med Assoc 252:84–91, 2018. cases, J Small Anim Pract 50:284–289, 2009.
172. Spugnini EP, Vincenzi B, Baldi F, et al.: Adjuvant electrochemo- 196. Rassnick KM, Bailey DB, Russell DS, et al.: A phase II study to
therapy for the treatment of incompletely resected canine mast cell evaluate the toxicity and efficacy of alternating CCNU and high-
tumors, Anticancer Res 26:4585–4589, 2006. dose vinblastine and prednisone (CVP) for treatment of dogs with
173. Spugnini EP, Vincenzi B, Citro G, et al.: Evaluation of cisplatin as an high-grade, metastatic or nonresectable mast cell tumours, Vet
electrochemotherapy agent for the treatment of incompletely excised Comp Oncol 8:138–152, 2010.
mast cell tumors in dogs, J Vet Intern Med 25:407–411, 2011. 197. Malone EK, Rassnick KM, Wakshlag JJ, et al.: Calcitriol (1,25-dihy-
174. Kodre V, Cemazar M, Pecar J, et al.: Electrochemotherapy com- droxycholecalciferol) enhances mast cell tumour chemotherapy and
pared to surgery for treatment of canine mast cell tumours, In Vivo receptor tyrosine kinase inhibitor activity in vitro and has single-
23:55–62, 2009. agent activity against spontaneously occurring canine mast cell
175. Lowe R, Gavazza A, Impellizeri JA, et al.: The treatment of canine tumours, Vet Comp Oncol 8:209–220, 2010.
mast cell tumors with electrochemotherapy with or without surgi- 198. Hayes A, Adams V, Smith K, et al.: Vinblastine and prednisolone
cal excision, Vet Comp Oncol 15:775–784, 2017. chemotherapy for surgically excised grade III canine cutaneous
176. Neyens IJ, Kirpensteijn J, Grinwis GC, et al.: Pilot study of intra- mast cell tumours, Vet Comp Oncol 5:168–176, 2007.
regional deionised water adjunct therapy for mast cell tumours in 199. Rassnick KM, Bailey DB, Flory AB, et al.: Efficacy of vinblastine
dogs, Vet Rec 154:90–91, 2004. for treatment of canine mast cell tumors, J Vet Intern Med 22:1390–
177. Grier RL, Di Guardo G, Schaffer CB, et al.: Mast cell tumor 1396, 2008.
destruction by deionized water, Am J Vet Res 51:1116–1120, 1990. 200. Vickery KR, Wilson H, Vail DM, et al.: Dose-escalating vinblas-
178. Grier RL, DiGuardo G, Myers R, et al.: Mast cell tumour destruc- tine for the treatment of canine mast cell tumour, Vet Comp Oncol
tion in dogs by hypotonic solution, J Sm An Pract 36:385–388, 6:111–119, 2008.
1995. 201. Singh J, Rana JS, Sood N, et al.: Clinico-pathological studies on
179. Jaffe MH, Hosgood G, Kerwin SC, et al.: The use of deionized the effect of different anti-neoplastic chemotherapy regimens on
water for the treatment of canine cutaneous mast cell tumors, Vet transmissible venereal tumours in dogs, Vet Res Commun 20:71–81,
Cancer Soc Newsl 22:9–10, 1998. 1996.